Abstract
The controlled release of therapeutic inorganic ions from biomaterials is an emerging area of international research. One of the foci for this research is the development of materials, which spatially and temporally modulate therapeutic release, via controlled degradation in the intended physiological environment. Crucially however, our understanding of the release kinetics for such systems remains limited, particularly with respect to the influence of physiological loading. Consequently, this study was designed to investigate the effect of dynamic mechanical loading on a composite material intended to stabilize, reinforce and strengthen vertebral bodies. The composite material contains a borate glass engineered to release strontium as a therapeutic inorganic ion at clinically relevant levels over extended time periods. It was observed that both cyclic (6 MPa 2 Hz) and static (4.3 MPa) compressive loading significantly increased the release of strontium ions in comparison to the static unloaded case. The observed alterations in ion release kinetics suggest that the mechanical loading of the implantation environment should be considered when evaluating the ion release kinetics.
Similar content being viewed by others
Introduction
Percutaneous vertebroplasty (PVP), is a minimally invasive technique through which bone cement is injected directly into a fractured vertebral body, providing mechanical support and immobilization without the need for invasive orthopedic surgery. PVP provides rapid fracture fixation for osteoporotic vertebral compression fractures, resulting in rapid pain relief for 88% of patients1. Despite the positive impact that PVP has on the quality of life for patients, subsequent fractures (in adjacent vertebrae), subsequent to the original, are frequently associated with procedural outcomes. While the etiology of adjacent fractures is complex, there is consensus in the literature that principal contributory factors, are compromised bone health (e.g. osteoporosis), and anatomical misalignment(s) caused by kyphotic deformity (a forward leaning arch of the spinal column)2. To address these factors, prophylactic augmentation of adjacent vertebrae has been proposed, and demonstrated, to increase the ability to resist loads which would cause fracture3; thereby providing a means to mitigate subsequent fracture rates. Furthermore, as subsequent fractures have been linked to the progression of osteoporosis, the inclusion of therapeutically active agents, capable of slowing the progression of osteoporosis is considered to add further benefits for patients undergoing PVP whilst decreasing fracture rate and improving quality of life.
One approach to achieving a therapeutically active biomaterial for PVP has been associated with the inclusion of strontium ions (Sr2+), a therapeutically active inorganic ion, into PVP bone cements. Several clinical studies have confirmed the beneficial effects of pharmacologically active Sr2+ on bone quality4,5,6,7,8. The concomitant mechanism of action associated with Sr2+ is related to its ability to act as both (i) an antiresorptive and (ii) an anabolic agent on bone metabolism9,10,11. However, while Sr2+ has beneficial effects on bone quality, through direct action on osteoblasts and osteoclast cell lines12, its release levels must be controlled to ensure temporal maintenance of Sr2+ levels within the therapeutic window. While a variety of approaches have been used to incorporate Sr into orthopedic biomaterials13,14 little work exists with respect to investigating such devices as drug releasing systems (i.e. therapeutic ion release systems); particularly with respect to investigating the release kinetics and temporal maintenance of therapeutic thresholds15.
For composite resin cements, intended for both dental and orthopedic applications, hydrophilic modifications have been used to alter ion release kinetics. Such modifications increase water sorption and therefore degradation of the inorganic filler phase; frequently a bioactive glass16,17. As filler degradation, and ion release are dependent on the movement of water through the system, degradation constrained by hydrostatic forces. Furthermore, the rate of glass dissolution has been shown to vary greatly depending on solution effects, slowing rapidly in constrained volumes when degradation products can accumulate at the glass-solution interface18. Due to the complexity of the implanted in vivo environment, and the ethical restrictions on the use of animal models, simplified in vitro elution models are frequently used to assess drug release. In particular, changes to the elution media (including ionic concentration and organic molecule interaction), along with flow through conditions have been explored to better understand those factors which govern in vivo release kinetics19,20.
However, the effects of dynamic loading on therapeutic ion release, has received little attention by comparison. This gap in our knowledge is significant, especially given the emergence of research pertaining to metals in medicine, and in particular with respect to the temporal modulation of therapeutic metal ion release from biomaterials21,22. In drug-releasing hydrogel materials, cyclic compressive loading has been demonstrated to significantly increase the rate release of reversibly bound drug particles23. This effect is attributed to variations in hydrostatic pressure, creating a periodic reversal of water flow in and out of the material. During unloaded phases, hydrophilic forces draw unsaturated fluid into the material generating swelling forces. In this unsaturated environment, water-soluble drugs are rapidly released into solution. Conversely, during the compressive loading phase compressive strain drives fluid from the material voids, into the bulk solution, which is replaced with unsaturated fluid in the next unloaded phase continuing the cycle. While vertebroplasty materials are much less compliant than hydrogel materials, the addition of small hydrophilic mono-functional monomers, such as poly- hydroxyl ethyl methacrylate (HEMA) to composite resins has been shown to not only alter water sorption behavior but also to reduce the modulus of elasticity of composite resins by up to 40%24. As such hydrophilic modifications of composite resin cements may result in loading dependent alterations of bioactive glass filler degradation kinetics. Accordingly, to design a Sr2+ releasing bone cement which can provide appropriate in vivo levels of ion release, the ion release kinetics under mechanically loaded conditions must also be fully considered.
This study aims to examine how dynamic loading of hydrophilic composite resins alters the movement of water into and out of the system, while also providing insights into the mechanisms of Sr2+ release from such materials. The methods and data generated in this paper may further help to evaluate and regulate the performance of ion releasing medical devices in the future. Accordingly, and to achieve the research objective, a highly degradable borate glass was selected as the reinforcing phase for a resin composite bone cement comprising conventional constituent polymers. The glass phase selected for this work has been previously studied, and is known to provide for Fickian controlled diffusion of Sr2+ up to 60 days25. A highly hydrophilic Bis glycydil dimethacrylate (Bis GMA), HEMA polymer blend was chosen as the resin phase of the composite; with the particular ratios of glass and HEMA content being based on previous investigations by MacDonald et al. to maximize ion release efficiency over 60 days15. Cement specimens produced in this study were exposed to three incubation conditions while immersed in simulated body fluid (SBF); (i) cyclic compressive loading, (ii) static loading, and (iii) an unloaded control condition. Ion release into solution was assessed using inductively coupled plasma optical emission spectroscopy (ICP-OES).
Results
Water sorption by cement samples was significantly decreased during cyclic loading (p < 0.05), with no decreases in water sorption being observed under static compression relative to unloaded samples (Fig. 1). The highest ion release levels were seen under cyclic compression loading, with the cumulative release of Sr and B reaching 68 and 57 mg respectively at 48 hours (Fig. 2). Cumulative release under static compression reached maximums of 24 and 22 mg for Sr and B respectively, while unloaded conditions achieved a maximum of 21 and 17 mg respectively. A significant increase in Sr release was seen in both the static (p < 0.05) and cyclic compression (p < 0.01) loading conditions relative to the unloaded control samples (Table 1), with the cyclic loading showing the greatest effect on cumulative ion release levels. While significant differences between static compression and unloaded samples at individual time points was observed only in the 1 and 6 hour samplings, an overall significant group effect (p < 0.001) was observed between each loading condition matching.
Akaikes informative criterion comparison of surface controlled, and diffusion controlled release models, preferred the more complex power series diffusion controlled release for all data sets (Table 2). When fitted to a modified Korsemyers Peppas model (with allowance for burst release effect26) power coefficients were (i) 0.499, 0.1835 and 0.360 for the release of Sr and (ii) 0.510, 0.306, 0.440 for the release of B under cyclic compression, static compression, and unloaded conditions respectively. While no significant difference was observed in the ratio of Sr to B released (supplemental Fig. 1) between loading conditions, a significant decrease (p < 0.01) was observed between early (1–3 h) time points and late (36–48 h) time points for the unloaded samples only. No significant changes were observed in the calcium concentration of the SBF over the 48 h experiment (Fig. 3). Significant decreases were observed for the 24, 36, and 48 h time points under cyclic compression, and for the 48 hour time point under static compression (Fig. 3).
Discussion
Sr release (24–48 mg/L after 48 h) was much higher than previous studies of a similar material in phosphate buffered saline15. Elution studies of a 45% HEMA, 26.5% Bis GMA, 26.5% triethylene glycol dimethacrylate (added as a diluent to reduce viscosity) reported strontium release levels below 4 mg/L after 24 hours, and below 20 mg/L after 60 days15. Release of B however was similar to previously reported values of 16 mg/L at 24 hours in both unloaded and statically compressed samples. These results suggest that the ionic composition of the elution media is of greater consequence for sparingly soluble elements such as Sr. Cumulative strontium release remained above the in vitro efficacy levels for osteoblast proliferation, but below in vitro osteoclast inhibitory levels (Fig. 4)9,10,27. While high levels of strontium are required to inhibit osteoclasts in monoculture, systemic therapy has proven to provide effective anti catabolic effects at serum levels as low as 10 mg/L27. This lowered threshold may be due to the osteoblast mediated decrease in osteoclast activity, as previously demonstrated by Tat et al., in which the threshold for decreased bone resorption was decreased from 174.4 mg/L with monoculture osteoclasts to 17.4 mg/L when co-cultures of osteoblasts and osteoclast precursors were investigated28. The serum Sr levels for co-cultured decreased resorption were reached after 24 hours under unloaded conditions, or 3 hours under cyclic loading demonstrating that the potential for anti-osteoporotic effect is increased under mechanical loading. Much greater overall release, under the cyclic loading condition, suggests that the static incubation conditions widely used for the investigation of strontium releasing bone cements will underestimate the true release levels and therefore impact effective local dosing. While these results highlight the importance of appropriate mechanical modeling of the implantation environment, appropriate selection of ratio of cement to SBF used would be needed to accurately predict Sr release in vitro. While studies focusing on the formation of apatite on the surface of bioactive glasses have suggested mass normalized incubation conditions with much lower glass to volume ratio than used in this study29, the surface to volume ratio utilized was constrained to 15 ml/cm2 due to the geometry of the mechanical testing environment used.
While cyclic loading increased therapeutic Sr release, it also increased the release of B raising a potential concern for cytotoxicity. Levels of boron exposure as low as 1.3 mM (14.5 ppm) have previously been associated with both decreased ALP activity, and osteoclast differentiation in in vitro conditions30. The use of dynamic incubation conditions is noted to have a strong effect on the cytotoxicity of borate bioactive glasses under in vitro conditions, with observed inhibition levels below expected inhibition based on ion release31. As such, no toxic effect has been observed in the direct culturing of MLO A5 cells on borate glass scaffolds despite expected boron concentration of up to 18 mM (194.4 mg/L)32,33. Similarly, animal implantation models have demonstrated favorable bone response to high borate glass materials34,35,36,37. While potential cytotoxic effect may be expected with the 58 mg release observed under in vitro testing conditions used in this study, further evaluation would be needed to assess the effect of boron release on cement biocompatibility.
While previous studies have reported a t1/2 dependence for ion release from bioactive glass reinforced composite resin dental materials38, such kinetics were only seen in the cyclic loading conditions of this study. In the static compression and unloaded conditions the power model coefficients were below 0.5, characteristic of “less Fickian” release39. This finding suggests that the polymer chain relaxation rate under the unloaded, and static compressive conditions is much faster than the rate of water penetration. This increased rate of relaxation is likely an effect of the high mono-functional HEMA content, decreasing the fraction of bi-functional monomers reducing crosslinking. Previous studies into the release of gentamycin from Poly methyl methacrylate bone cements reported crack surface mediated increases in drug release rates. A study of antibiotic loaded cements under uniaxial sinusoidal tension-compression (±10 MPa at a frequency of 2 Hz) resulted in a three-fold increase in the rate of gentamicin released versus statically incubated samples; with both conditions displaying surface controlled release40. It was proposed that the increased rate of release was due to crack formation providing an increased surface area for drug elution. When a 400 KPa 5 Hz compressive force was applied to the stem of a cemented hip prosthesis in a model elution environment (cement stresses of −2 MPa to 6 MPa) minor increases in antibiotic elution were seen only in a highly porous cement formulation over 28 days of elution testing but no alterations to the mechanism of release were reported41. While crack surface mediated release mechanisms are considered in the literature, such a mechanism is unlikely to explain the results seen in this study, as any increase in surface area would result in increased water sorption.
Results from this study, in contrast, indicate significant alterations to the mechanism of release of Sr2+ as a result of physiological loading variations. Increases to power law release coefficients suggest that compressive loading decreased both the rate of water sorption and polymer chain relaxation in both cyclic and static conditions. Mechanical loading of hydrogels has been demonstrated to alter release kinetics only for reversibly bound growth factors. Such an effect may explain the alteration in kinetics seen in this study. Polar pendant groups in hydrophilic poly HEMA materials are associated with cation chelation in their hydrated state42, providing both a mechanism of hydrogel calcification and bone integration. While cyclic loading alters local concentration gradients, allowing for increased ion release, compressive loading also resulted in slower chain relaxation, decreased pendant group exposure, and potentially decreased cation chelation. Compressive loading however also resulted in mineralization as evidenced by a significant decrease in phosphorous content in solution for both cyclic and static compression loading, (no evidence of mineralization was observed for the unloaded condition). While the decrease in the ratio of strontium to boron released from the unloaded sample may be evidence of retention of strontium within the cement sample, no decrease in phosphate was observed suggesting this effect was not likely to be the result of strontium phosphate formation. The mechanism underlying the increased rate of ion release under static compressive loading, despite decreased water sorption, remains unclear. Due to the use of silica free glass in this study salinization was not performed, and the filler was thus uncoupled, potentially resulting in increased surface filler loss43. The increased rates of water sorption and chain relaxation observed in the unloaded specimens would suggest increased matrix swelling, which may have served to retain a higher fraction of surface particles, and contributed to the lower rates of ion release in these samples. Imaging of the hydrated resin surface would be required to verify if changes to filler loss occurred between loading conditions. Alternatively, further investigation into the mineral phase formed, and if it is located (1) at the glass surface due to altered glass degradation, (2) at the resin surface due to changes in the relaxation rate of the polymer, or (3) within the bulk of the solution due to saturation effects, would be needed to better understand this phenomena. Surface analysis through XRD, or SEM would be of utility to provide further insight into how compressive loading results in increased release.
While continuous cyclic loading is standard in material testing, in vivo loading would present fewer, intermittent loading cycles, with ASTM F2118 standards for cyclic testing of acrylic bone cement reporting an average of 2–3 million steps a year44. As such the 7,200 loading cycles per hour used in this study would approximate a full day of activity, with the 48 h duration approximating 48 days of activity. While this is a short duration study, this may indicate a potential mechanism to extend the effective window of testing.
The loading levels selected in this study were based on computational models assessing the cement stress levels during walking following vertebral body augmentation, assuming fill volumes of ca. 8 ml45. True loading values may vary significantly due to the variability in fill pattern and irregularly shaped cement volume seen following vertebroplasty46. Previous models have predicted cement stress as low as 1.5 MPa within the cement bolus (based on an assumption of 70% fill)47. Furthermore the elastic modulus of trabecular bone can vary by orders of magnitude in even healthy individuals, adding variability to the extent of stress shielding, while kyphotic angle has been reported in increased quasi-static compressive forces by as much as 2–3% per degree of kyphosis48,49. As such our limitations in predicting the loading levels in augmented vertebrae limits our ability to predict cement behavior, including ion release kinetics. Similarly, it is important to note that the implantation environment is temporally heterogeneous, and would be expected to change over the course of healing. Specifically, changes in blood flow, local cellular activity, and load distributions would be expected to evolve as the fracture heals. While the results of this study demonstrate the ability of cyclic loading conditions to alter ion release kinetics over a short period of investigation, further investigation into the threshold of this effect, as well as long-term release behavior is merited. Along with variations in loading conditions, alterations to solution media, notably the inclusion of serum proteins would serve to better mimic the true implantation environment deepening our understanding of material host interactions which mediate ion release.
Conclusion
Both cyclic and static compressive stress has been demonstrated to shown to yield a significant increase in ion release from a borate glass filled composite resins (relative to unloaded release conditions). Cyclic loading conditions may provide a mechanism of extending the time frame for diffusion-controlled release of therapeutic inorganic ions from such systems, despite the decrease in water sorption caused by compression. The study results indicate that the mechanical loading environment should be considered when assessing the release kinetics of a drug loaded bone augmentation material for both toxic and therapeutic effects.
Methods
A two paste chemically cured resin blend was fabricated from a blend of Bis Glycydil Dimethacrylate (Bis-GMA) and Hydroxyl Ethyl Methacrylate (HEMA) based on the compositions in Table 3, mixed in the appropriate weight ratios with either benzyl peroxide (BPO), or 2,2′-(4-Methylphenylimino) diethanol (DHEPT), to initiate the free radical polymerisation reaction upon mixing. Resin blends were shielded from light and mixed in a shaking incubator at 37 °C, 2 Hz overnight to achieve homogeneous mixture. The borate-glass reinforcing phase was fabricated as described by MacDonald et al.25, ground and sieved to retrieve sub 45 micron particles. Each cement paste was formed from a mixture of glass filler (60 wt %) mixed to homogeneity with either resin part one or two (40 wt %), through hand spatulation. Cement cylinders were fabricated using a cylindrical aluminum split mold (4 cm diameter, 3 cm height) filled with an equal mixture of the two pastes (40 g/paste, 80 g total) through hand spatulation, clamped between two stainless steel plates, and allowed to cure for and hour. Samples were removed from the mold, and stored in a desiccator overnight until the elution study.
Incubation conditions
Cylindrical cement samples (n = 4 per loading condition) were incubated at 37 °C in 950 ml (surface to volume ration of 15 ml/cm2) simulated body fluid50 for 48 hours under three loading conditions: (a) no mechanical loading, (b) cyclic compressive loading and (c) static compressive loading. Both cyclic and static compressive loading was performed using a Bose Electroforce 3510 system (TA Instruments, MN). Environmental control tank volume was reduced to approximately 1.5 L by the fixation of an acrylic cylinder (approximately 12.5 cm diameter, 25 cm height) to the chamber base centered around the loading platform using silicone marine adhesive on the outside rim. The outer tank was filled with water during testing to improve heat conduction from elements and stabilize temperature. Cyclic loading was performed as a compression-compression sinusoidal waveform, oscillating between 0.3 to 6 MPa at a frequency of 2 Hz. Static compressive loading was performed at 4.3 MPa (the equivalent RMS value of the cyclic loading conditions). Incubation media was sampled through the removal of 5 ml of SBF at 1, 2, 3, 5, 6, 8, 12, 24, 36 and 48 h, and replaced with 5 ml of fresh simulated body fluid.
Water sorption measurements
Cement cylinders were removed from solution and patted dry of excess SBF before the measurement of wet weight. Cylinders were then dried in a 45 °C oven until constant mass was achieved and dry weight was recorded (approximately 7 days). Water sorption was recorded as the difference between wet and dry weights.
Ion release
Ion release profiles were assessed through the use of inductively coupled plasma optical emission spectroscopy, for the presence of phosphorous, calcium, boron and strontium in solution. Extract media was diluted in 2% HCl to 1:6, 1:6000, 1:100 and 1:1000 dilutions for the assessment of phosphorous, calcium, boron and strontium respectively. ICP-OES measurements were performed in triplicate, against a standard calibration curve, and corrected for the removal of simulated body fluid during sampling. Ion release profiles were fitted through least squares regression to diffusion controlled release models, with model parameters compared between elution conditions using a corrected Akaike’s Information Criterion51 using Prism 6 (GraphPad Software, Ca). Two way ANOVA with Turkey’s multiple comparison honesty test was performed comparing ion release between loading states and time points using Prism 6.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Anselmetti, G. et al. Percutaneous vertebroplasty: multi-centric results from EVEREST experience in large cohort of patients. Eur. J. Radiol. 81, 4083–4086 (2012).
Wang, J., Chiang, C., Kuo, Y., Chou, W. & Yang, B. Mechanism of fractures of adjacent and augmented vertebrae following simulated vertebroplasty. J. Biomech. 45, 1372–1378 (2012).
Aquarius, R., Homminga, J., Hosman, A. J. F., Verdonschot, N. & Tanck, E. Prophylactic vertebroplasty can decrease the fracture risk of adjacent vertebrae: An in vitro cadaveric study. Medical Engineering & Physics 36, 944–948 (2014).
Marie, P., Felsenberg, D. & Brandi, M. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporosis Int. 22, 1659–1667 (2011).
Blake, G. M., Lewiecki, E. M., Kendler, D. L. & Fogelman, I. A review of strontium ranelate and its effect on DXA scans. Journal of Clinical Densitometry 10, 113–119 (2007).
Bolland, M. J. & Grey, A. A comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication record. BMJ Open 4, e005787–2014-005787 (2014).
Grosso, A., Douglas, I., Hingorani, A., MacAllister, R. & Smeeth, L. Post‐marketing assessment of the safety of strontium ranelate; a novel case‐only approach to the early detection of adverse drug reactions. Br. J. Clin. Pharmacol. 66, 689–694 (2008).
Reginster, J. et al. Strontium ranelate: Dose-dependent effects in postmenopausal osteoporosis: The STRATOS 2-year randomised trial. Clin. Rheumatol. 20, 427–428 (2001).
Bonnelye, E., Chabadel, A., Saltel, F. & Jurdic, P. Dual effect of strontium ranelate: Stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 42, 129–138 (2008).
Chattopadhyay, N., Quinn, S. J., Kifor, O., Ye, C. & Brown, E. M. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem. Pharmacol. 74, 438–447 (2007).
Hurtel-Lemaire, A. S. et al. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. J. Biol. Chem. 284, 575–584 (2009).
Saidak, Z. & Marie, P. J. Strontium signaling: Molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol. Ther. 136, 216–226 (2012).
Panzavolta, S. et al. Setting properties and in vitro bioactivity of strontium‐enriched gelatin–calcium phosphate bone cements. Journal of Biomedical Materials Research Part A 84, 965–972 (2008).
Schumacher, M., Lode, A., Helth, A. & Gelinsky, M. A novel strontium (II)-modified calcium phosphate bone cement stimulates human-bone-marrow-derived mesenchymal stem cell proliferation and osteogenic differentiation in vitro. Acta biomaterialia 9, 9547–9557 (2013).
MacDonald, K., Price, R. B. & Boyd, D. The Feasibility and Functional Performance of Ternary Borate-Filled Hydrophilic Bone Cements: Targeting Therapeutic Release Thresholds for Strontium. Journal of Functional Biomaterials 8, 28 (2017).
Hashimoto, M. Effect of monomer composition on crystal growth by resin containing bioglass. Journal of biomedical materials research. Part B, Applied biomaterials 94, 127 (2010).
Skrtic, D. Effect of the monomer and filler systems on the remineralizing potential of bioactive dental composites based on amorphous calcium phosphate. Polym. Adv. Technol. 12, 369 (2001).
Filgueiras, M. R., La Torre, G. & Hench, L. L. Solution effects on the surface reactions of a bioactive glass. Journal of Biomedical Materials Research Part A 27, 445–453 (1993).
Mourino, V. & Boccaccini, A. R. Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J. R. Soc. Interface 7, 209–227 (2010).
Gbureck, U., Vorndran, E. & Barralet, J. E. Modeling vancomycin release kinetics from microporous calcium phosphate ceramics comparing static and dynamic immersion conditions. Acta biomaterialia 4, 1480–1486 (2008).
Mouriño, V., Cattalini, J. P. & Boccaccini, A. R. Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. Journal of The Royal Society Interface 9, 401–419 (2012).
Hoppe, A., Mouriño, V. & Boccaccini, A. R. Therapeutic inorganic ions in bioactive glasses to enhance bone formation and beyond. Biomaterials Science 1, 254–256 (2013).
Lee, K. Y., Peters, M. C., Anderson, K. W. & Mooney, D. J. Controlled growth factor release from synthetic extracellular matrices. Nature 408, 998–1000 (2000).
Ito, S. et al. Effects of resin hydrophilicity on water sorption and changes in modulus of elasticity. Biomaterials 26, 6449–6459 (2005).
MacDonald, K., Hanson, M. A. & Boyd, D. Modulation of strontium release from a tertiary borate glass through substitution of alkali for alkali earth oxide. J. Non Cryst. Solids 443, 184–191 (2016).
Frutos Cabanillas, P., Dı́ez Peña, E., Barrales-Rienda, J. M. & Frutos, G. Validation and in vitro characterization of antibiotic-loaded bone cement release. International Journal of Pharmaceutics 209, 15–26 (2000).
Reginster, J. et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. Journal of Clinical Endocrinology & Metabolism 90, 2816–2822 (2005).
Tat, S. K., Pelletier, J., Mineau, F., Caron, J. & Martel-Pelletier, J. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone 49, 559–567 (2011).
Maçon, A. L. et al. A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J. Mater. Sci. Mater. Med. 26, 115 (2015).
Fu, H. et al. In vitro evaluation of borate-based bioactive glass scaffolds prepared by a polymer foam replication method. Materials Science and Engineering: C 29, 2275–2281 (2009).
Brown, R. F. et al. Effect of borate glass composition on its conversion to hydroxyapatite and on the proliferation of MC3T3-E1 cells. Journal of Biomedical Materials Research Part A 88A, 392–400 (2009).
Fu, Q., Rahaman, M. N., Fu, H. & Liu, X. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. I. Preparation and in vitro degradation. Journal of Biomedical Materials Research Part A 95A, 164–171 (2010).
Fu, Q. et al. Silicate, borosilicate, and borate bioactive glass scaffolds with controllable degradation rate for bone tissue engineering applications. II. In vitro and in vivo biological evaluation. Journal of Biomedical Materials Research Part A 95A, 172–179 (2010).
O’Connell, K. et al. Host responses to a strontium releasing high boron glass using a rabbit bilateral femoral defect model. Journal of Biomedical Materials Research Part B: Applied Biomaterials 105, 1818–1827 (2017).
Xie, Z. et al. Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin. J. Controlled Release 139, 118–126 (2009).
Zhao, S. et al. Wound dressings composed of copper-doped borate bioactive glass microfibers stimulate angiogenesis and heal full-thickness skin defects in a rodent model. Biomaterials 53, 379–391 (2015).
Zhang, J. et al. Bioactive borate glass promotes the repair of radius segmental bone defects by enhancing the osteogenic differentiation of BMSCs. Biomedical Materials 10, 065011 (2015).
Wiegand, A., Buchalla, W. & Attin, T. Review on fluoride-releasing restorative materials—fluoride release and uptake characteristics, antibacterial activity and influence on caries formation. Dental materials 23, 343–362 (2007).
Ganji, F., Vasheghani-Farahani, S. & Vasheghani-Farahani, E. Theoretical description of hydrogel swelling: a review. Iran Polym J 19, 375–398 (2010).
Lewis, G. & Janna, S. The in vitro elution of gentamicin sulfate from a commercially available gentamicin‐loaded acrylic bone cement, VersaBond™ AB. Journal of Biomedical Materials Research Part B: Applied Biomaterials 71, 77–83 (2004).
Hendriks, J. G. et al. The influence of cyclic loading on gentamicin release from acrylic bone cements. J. Biomech. 38, 953–957 (2005).
Zecheru, T. et al. Biomimetic potential of some methacrylate‐based copolymers: A comparative study. Biopolymers 91, 966–973 (2009).
Condon, J. & Ferracane, J. In vitro wear of composite with varied cure, filler level, and filler treatment. J. Dent. Res. 76, 1405–1411 (1997).
Standard Test Method for Constant Amplitude of Force Controlled Fatigue Testing of Acrylic Bone Cement Materials (2014).
Rohlmann, A., Boustani, H. N., Bergmann, G. & Zander, T. A probabilistic finite element analysis of the stresses in the augmented vertebral body after vertebroplasty. European Spine Journal 19, 1585–1595 (2010).
Tanigawa, N. et al. Relationship between cement distribution pattern and new compression fracture after percutaneous vertebroplasty. Am. J. Roentgenol. 189, W348–W352 (2007).
Hadley, C., Awan, O. A. & Zoarski, G. H. Biomechanics of Vertebral Bone Augmentation. Neuroimaging Clinics of North America 20, 159–167 (2010).
Rincón-Kohli, L. & Zysset, P. K. Multi-axial mechanical properties of human trabecular bone. Biomechanics and modeling in mechanobiology 8, 195–208 (2009).
Bruno, A. G., Anderson, D. E., D’Agostino, J. & Bouxsein, M. L. The effect of thoracic kyphosis and sagittal plane alignment on vertebral compressive loading. Journal of Bone and Mineral Research 27, 2144–2151 (2012).
Kokubo, T., Kushitani, H., Ohtsuki, C., Sakka, S. & Yamamuro, T. Chemical reaction of bioactive glass and glass-ceramics with a simulated body fluid. J. Mater. Sci. Mater. Med. 3, 79–83 (1992).
Yamaoka, K., Nakagawa, T. & Uno, T. Application of Akaike’s information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6, 165–175 (1978).
Wornham, D., Hajjawi, M., Orriss, I. & Arnett, T. Strontium potently inhibits mineralisation in bone-forming primary rat osteoblast cultures and reduces numbers of osteoclasts in mouse marrow cultures. Osteoporosis Int. 25, 2477–2484 (2014).
Acknowledgements
The authors would like to thank the Atlantic Canadian Opportunities Agency for providing financial support to this project.
Author information
Authors and Affiliations
Contributions
Both K.M. and D.B. conceived and designed the experiments, and revised the manuscript; K.M. performed the experiments, analyzed the data, and wrote the paper.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
MacDonald, K., Boyd, D. Mechanical loading, an important factor in the evaluation of ion release from bone augmentation materials. Sci Rep 8, 14225 (2018). https://doi.org/10.1038/s41598-018-32325-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-32325-1
Keywords
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.